Bruno, Savino
 Distribuzione geografica
Continente #
NA - Nord America 1.435
EU - Europa 545
AS - Asia 159
AF - Africa 2
OC - Oceania 1
Totale 2.142
Nazione #
US - Stati Uniti d'America 1.430
GB - Regno Unito 174
IT - Italia 113
DE - Germania 87
SE - Svezia 82
HK - Hong Kong 38
CN - Cina 33
SG - Singapore 29
TR - Turchia 27
IN - India 23
UA - Ucraina 22
FI - Finlandia 15
BG - Bulgaria 13
BE - Belgio 10
FR - Francia 8
RU - Federazione Russa 4
CA - Canada 3
ID - Indonesia 3
LT - Lituania 3
AL - Albania 2
BZ - Belize 2
CZ - Repubblica Ceca 2
MY - Malesia 2
NL - Olanda 2
PL - Polonia 2
RO - Romania 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
AU - Australia 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
Totale 2.142
Città #
Fairfield 250
Chandler 143
Southend 139
Woodbridge 134
Ashburn 133
Seattle 112
Houston 98
Wilmington 82
Cambridge 72
Ann Arbor 68
Modena 68
Nyköping 60
Dearborn 41
Hong Kong 38
Jacksonville 32
Izmir 24
New York 20
Singapore 20
San Diego 17
Bremen 14
Helsinki 14
Princeton 13
Sofia 13
Grafing 11
Brussels 10
Beijing 8
Des Moines 8
Eugene 8
Redwood City 8
Shanghai 7
Augusta 4
London 4
Munich 4
Naples 4
Rome 4
Boardman 3
Chicago 3
Fremont 3
Jakarta 3
Los Angeles 3
Monmouth Junction 3
Mumbai 3
San Mateo 3
Belize City 2
Brno 2
Cardano al Campo 2
Dallas 2
Jinan 2
Kilburn 2
Lanzhou 2
Leawood 2
Muizenberg 2
Phoenix 2
Acton 1
Amsterdam 1
Apo 1
Ardabil 1
Ascoli Piceno 1
Birmingham 1
Citta 1
Cividale Del Friuli 1
Clearwater 1
Dublin 1
Hangzhou 1
Indiana 1
Islington 1
Lisbon 1
Markham 1
Milan 1
Modesto 1
Montefiore Conca 1
Montréal 1
Napoli 1
Novokuznetsk 1
Ottawa 1
Padova 1
Pontevedra 1
Prescot 1
Reggio Emilia 1
Reggio Nell'emilia 1
Rho 1
San Francisco 1
Shaoxing 1
Sydney 1
Targu 1
Tokyo 1
Torino 1
Vienna 1
Washington 1
Yerevan 1
Totale 1.766
Nome #
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 299
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 273
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 271
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 193
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 193
From current status to optimization of HCV treatment: Recommendations from an expert panel 158
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 157
Current and future challenges in HCV: insights from an Italian experts panel 150
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon 119
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 116
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 111
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 77
Preoperative Risk Factors for Access Site Failure in Ultrasound-Guided Percutaneous Treatment of TASC C and D Aorto-Iliac Occlusive Disease 38
Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study 20
Totale 2.175
Categoria #
all - tutte 9.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020361 30 8 9 18 33 85 61 33 41 15 21 7
2020/2021639 29 15 41 49 97 61 138 50 27 70 48 14
2021/2022305 20 22 9 19 7 24 20 27 31 33 62 31
2022/2023351 46 48 33 39 42 48 8 34 29 0 11 13
2023/2024192 5 12 15 21 26 22 20 20 7 5 11 28
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.175